Press Releases on March 6, 2024 - EIN Presswire - Press Release Distribution Service

Published on March 6, 2024 - 21:05 GMT

Larimar Therapeutics to Present at the Leerink Partners Global Biopharma Conference

BALA CYNWYD, Pa., March 06, 2024 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (“Larimar”) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, today announced that members of the company’s …

Distribution channels: Culture, Society & Lifestyle, Technology ...

Published on March 6, 2024 - 21:05 GMT

Madrigal Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

CONSHOHOCKEN, Pa., March 06, 2024 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a clinical-stage biopharmaceutical company pursuing novel therapeutics for nonalcoholic steatohepatitis (NASH), today announced that the company granted …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...

Published on March 6, 2024 - 21:05 GMT

Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

WALTHAM, Mass., March 06, 2024 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the company approved the grant of equity awards to one new employee with a grant date of March 1, 2024, as equity inducement awards outside …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on March 6, 2024 - 21:05 GMT

AIU Announces Receipt of NYSE Non-compliance Letter Regarding ADS Trading Price

Hong Kong, March 06, 2024 (GLOBE NEWSWIRE) -- Meta Data Limited (NYSE: AIU) (“Meta Data” or the “Company”) today announced the Company has received a letter from the New York Stock Exchange (the "NYSE") dated March 4, 2024, notifying the Company …

Distribution channels: Consumer Goods, Media, Advertising & PR ...

Published on March 6, 2024 - 21:05 GMT

GEN Restaurant Group, Inc. Announces Fourth Quarter 2023 Financial Results

CERRITOS, Calif., March 06, 2024 (GLOBE NEWSWIRE) -- GEN Restaurant Group, Inc. (“GEN” or the “Company”), owner of GEN Korean BBQ, a fast-growing cook-it-yourself casual dining concept, today announced financial results for the fourth quarter and year …

Distribution channels:

Published on March 6, 2024 - 21:05 GMT

Sow Good to Hold Fourth Quarter and Full Year 2023 Conference Call on Friday, March 22, 2024 at 10:00 a.m. ET

IRVING, Texas, March 06, 2024 (GLOBE NEWSWIRE) -- Sow Good Inc. (OTCQB: SOWG) (“Sow Good” or “the Company”), a trailblazer in the freeze dried candy and treat industry, will hold a conference call on Friday, March 22, 2024 at 10:00 a.m. Eastern time to …

Distribution channels: Food & Beverage Industry ...

Published on March 6, 2024 - 21:05 GMT

Phunware to Participate in the 36th Annual ROTH Conference

AUSTIN, Texas, March 06, 2024 (GLOBE NEWSWIRE) -- Phunware, Inc. (Nasdaq: PHUN, “Phunware” or the “Company”), the leading provider of patented wayfinding and mobile engagement solutions for mobile that enables brands to engage, manage and monetize anyone …

Distribution channels: Culture, Society & Lifestyle, IT Industry ...

Published on March 6, 2024 - 21:05 GMT

SuRo Capital Corp. to Report Fourth Quarter and Fiscal Year 2023 Financial Results on Wednesday, March 13, 2024

NEW YORK, March 06, 2024 (GLOBE NEWSWIRE) -- SuRo Capital Corp. (“SuRo Capital”) (Nasdaq: SSSS) today announced that it will report its financial results for the quarter and fiscal year ended December 31, 2023 after the close of the U.S. market on …

Distribution channels:

Published on March 6, 2024 - 21:05 GMT

Hudson Technologies Reports Fourth Quarter and Year End 2023 Results

WOODCLIFF LAKE, N.J., March 06, 2024 (GLOBE NEWSWIRE) -- Hudson Technologies, Inc. (NASDAQ: HDSN) announced results for the fourth quarter and year ended December 31, 2023. For the quarter ended December 31, 2023, Hudson reported revenues of $44.9 million, …

Distribution channels: Business & Economy ...

Published on March 6, 2024 - 21:05 GMT

Lulus Reports Fourth Quarter and Fiscal Year 2023 Results

Expanded Gross Margin in Fourth Quarter 2023 by 180 bps, compared to Fourth Quarter 2022 Grew Fiscal Year 2023 Net Cash Provided by Operating Activities by 149%, $9.2 million from Fiscal Year 2022 Grew Fiscal Year 2023 Free Cash Flow by 867%, $10.3 million …

Distribution channels: Business & Economy, Retail ...

Published on March 6, 2024 - 21:05 GMT

OrthoPediatrics Corp. Reports Fourth Quarter and Full Year 2023 Financial Results

WARSAW, Ind., March 06, 2024 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today its financial results for the fourth …

Distribution channels:

Published on March 6, 2024 - 21:05 GMT

Cardiff Oncology Announces Upcoming Presentations at the AACR Annual Meeting 2024

SAN DIEGO, March 06, 2024 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers, today announced publications of five abstracts that …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on March 6, 2024 - 21:05 GMT

Soleno Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2023 Financial Results

REDWOOD CITY, Calif., March 06, 2024 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today provided a corporate update, and …

Distribution channels:

Published on March 6, 2024 - 21:05 GMT

Five Below, Inc. Announces Fourth Quarter and Full Year Fiscal 2023 Earnings Release and Conference Call Date

PHILADELPHIA, PA, March 06, 2024 (GLOBE NEWSWIRE) -- Five Below, Inc. (NASDAQ: FIVE), the trend-right, high-quality, extreme-value retailer for tweens, teens and beyond, today announced that its financial results for the fourth quarter and full year of …

Distribution channels: Culture, Society & Lifestyle, Retail ...

Published on March 6, 2024 - 21:05 GMT

Amplify Energy Announces Fourth Quarter and Full-Year 2023 Results, Year-End 2023 Proved Reserves and Full-Year 2024 Guidance

HOUSTON, March 06, 2024 (GLOBE NEWSWIRE) -- Amplify Energy Corp. (NYSE: AMPY) (“Amplify,” the “Company,” “us,” or “our”) announced today its operating and financial results for the fourth quarter and full-year 2023, year-end 2023 proved reserves and …

Distribution channels: Business & Economy, Mining Industry ...

Published on March 6, 2024 - 21:03 GMT

Infinera Corporation Announces Preliminary Unaudited Fourth Quarter 2023 Financial Results

SAN JOSE, Calif., March 06, 2024 (GLOBE NEWSWIRE) -- Infinera Corporation (NASDAQ: INFN) ("Infinera" or the “Company”) today released preliminary financial results for its fourth quarter ended December 30, 2023. For the fourth quarter, …

Distribution channels:

Published on March 6, 2024 - 21:02 GMT

HighPeak Energy, Inc. Announces Fourth Quarter and Yearend 2023 Financial and Operating Results and Provides 2024 Guidance

FORT WORTH, Texas, March 06, 2024 (GLOBE NEWSWIRE) -- HighPeak Energy, Inc. (“HighPeak” or the “Company”) (NASDAQ: HPK) today announced financial and operating results for the quarter and the year ended December 31, 2023. In addition, HighPeak provided its …

Distribution channels: Business & Economy ...

Published on March 6, 2024 - 21:01 GMT

مؤتمر ميفما يبرز التوجهات والابتكارات في سوق إدارة المرافق في الكويت

مشاريع استراتيجية نحو رؤية 2035 واستثمارات البنية التحتية والتعليم والرعاية الصحية والتنمية الحضرية الكويت, March 7, 2024 /⁨EINPresswire.com⁩/ -- نحو إبراز التوجهات والابتكارات في سوق إدارة المرافق في الكويت، عقدت جمعية الشرق الأوسط لإدارة المرافق مؤتمر …

Distribution channels: Building & Construction Industry, Business & Economy ...

Published on March 6, 2024 - 21:01 GMT

PepGen Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate Developments

- Enrollment completed for PGN-EDO51 5 mg/kg cohort in CONNECT1-EDO51 Phase 2 clinical trial in DMD patients. The Company expects to announce preliminary data from the 5 mg/kg dose cohort in mid-2024 – - CONNECT2-EDO51 Phase 2 clinical trial in DMD …

Distribution channels:

Published on March 6, 2024 - 21:01 GMT

scPharmaceuticals to Announce Fourth Quarter and Full-Year 2023 Financial Results on Wednesday, March 13, 2024

BURLINGTON, Mass., March 06, 2024 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize therapies, advance patient care, and reduce …

Distribution channels: